The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins
Open accessAbstract
Hepatitis C virus (HCV) and triglyceride-rich very low-density lipoproteins (VLDLs) both are secreted uniquely by hepatocytes and circulate in blood in a complex. Here, we isolated from human hepatoma cells the membrane vesicles in which HCV replicates. These vesicles, which contain the HCV replication complex, are highly enriched in proteins required for VLDL assembly, including apolipoprotein B (apoB), apoE, and microsomal triglyceride transfer protein. In hepatoma cells that constitutively produce infectious HCV, HCV production is reduced by two agents that block VLDL assembly: an inhibitor of microsomal triglyceride transfer protein and siRNA directed against apoB. These results provide a possible explanation for the restriction of HCV production to the liver and suggest new cellular targets for treatment of HCV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSEMBLY OF ASPARAGINE-LINKED OLIGOSACCHARIDES
Kornfeld, R., & Kornfeld, S. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.003215 · Cited by 4,906
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
Blight, K. J., McKeating, J. A., & Rice, C. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13001-13014.2002 · Cited by 1,193
The mechanism of Z α1-antitrypsin accumulation in the liver
Lomas, D. A., LI-Evans, D., Finch, J. T., & Carrell, R. W. (1992) · Nature · doi:10.1038/357605a0 · Cited by 1,053
Egger, D., Wölk, B., Gosert, R., Bianchi, L., Blum, H. E., Moradpour, D., & Bienz, K. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.5974-5984.2002 · Cited by 867
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
André, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J. L., Sodoyer, M., Pol, S., Bréchot, C., Paranhos-Baccalà, G., & Lotteau, V. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.6919-6928.2002 · Cited by 690
Gosert, R., Egger, D., Lohmann, V., Bartenschlager, R., Blum, H. E., Bienz, K., & Moradpour, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5487-5492.2003 · Cited by 635
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
Cuchel, M., Bloedon, L. T., Szapary, P. O., Kolansky, D. M., Wolfe, M. L., Sarkis, A., Millar, J. S., Ikewaki, K., Siegelman, E. S., Gregg, R. E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061189 · Cited by 580
Fisher, E. A., & Ginsberg, H. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100068200 · Cited by 460
Sharp, D., Blinderman, L., Combs, K. A., Kienzle, B., Ricci, B., Wager-Smith, K., Gil, C. M., Turck, C. W., Boumas, M.-E., Rader, D. J., et al. (1993) · Nature · doi:10.1038/365065a0 · Cited by 393
Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection
Loo, Y.-M., Owen, D. M., Li, K., Erickson, A. K., Johnson, C. L., Fish, P. M., Carney, D. S., Wang, T., Ishida, H., Yoneyama, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601523103 · Cited by 391
Self-citationYe, J., Wang, C., Sumpter, R., Brown, M. S., Goldstein, J. L., & Gale, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237238100 · Cited by 366
Self-citationBrass, V., Bieck, E., Montserret, R., Wölk, B., Hellings, J. A., Blum, H. E., Penin, F., & Moradpour, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111289200 · Cited by 365
Nielsen, S. U., Bassendine, M. F., Burt, A. D., Martin, C., Pumeechockchai, W., & Toms, G. L. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2418-2428.2006 · Cited by 347
OLOFSSON, S. ‐., & BORÈN, J. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01556.x · Cited by 330
A proposed model for the assembly of chylomicrons
Mahmood Hussain, M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00397-4 · Cited by 310
Very-low-density lipoprotein assembly and secretion
Shelness, G. S., & Sellers, J. A. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00008 · Cited by 309
Serfaty, L., Andreani, T., Giral, P., Carbonell, N., Chazouillères, O., & Poupon, R. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00036-2 · Cited by 299
Mobilisation of triacylglycerol stores
Gibbons, G. F., Islam, K., & Pease, R. J. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00182-1 · Cited by 297
An MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL Rabbits
Wetterau, J. R., Gregg, R. E., Harrity, T. W., Arbeeny, C., Cap, M., Connolly, F., Chu, C.-H., George, R. J., Gordon, D. A., Jamil, H., et al. (1998) · Science · doi:10.1126/science.282.5389.751 · Cited by 267
Self-citationRaabe, M., Flynn, L. M., Zlot, C. H., Wong, J. S., Véniant, M. M., Hamilton, R. L., & Young, S. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8686 · Cited by 256
Synthesis and function of hepatic very-low-density lipoprotein
Gibbons, G. F., Wiggins, D., Brown, A.-M., & Hebbachi, A.-M. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320059 · Cited by 254
Unscrambling hepatitis C virus–host interactions
Chisari, F. V. (2005) · Nature · doi:10.1038/nature04076 · Cited by 224
From Structure to Function: New Insights into Hepatitis C Virus RNA Replication
Appel, N., Schaller, T., Penin, F., & Bartenschlager, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r500026200 · Cited by 202
Tolleshaug, H., Goldstein, J. L., Schneider, W. J., & Brown, M. S. (1982) · Cell · doi:10.1016/0092-8674(82)90276-8 · Cited by 186
Chandler, C. E., Wilder, D. E., Pettini, J. L., Savoy, Y. E., Petras, S. F., Chang, G., Vincent, J., & Harwood, H. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300094-jlr200 · Cited by 177
COPII vesicles derived from mammalian endoplasmic reticulum microsomes recruit COPI.
Rowe, T., Aridor, M., McCaffery, J. M., Plutner, H., Nuoffer, C., & Balch, W. E. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.4.895 · Cited by 166
Gusarova, V., Brodsky, J. L., & Fisher, E. A. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306898200 · Cited by 155
Characterization of monoclonal antibodies against human low density lipoprotein.
Milne, R. W., Théolis, R., Verdery, R. B., & Marcel, Y. L. (1983) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.3.1.23 · Cited by 145
El‐Hage, N., & Luo, G. G. (2003) · Journal of General Virology · doi:10.1099/vir.0.19305-0 · Cited by 135
Kato, T., Date, T., Miyamoto, M., Zhao, Z., Mizokami, M., & Wakita, T. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.592-596.2005 · Cited by 125
Randhawa, V. K., Bilan, P. J., Khayat, Z. A., Daneman, N., Liu, Z., Ramlal, T., Volchuk, A., Peng, X., Coppola, T., Regazzi, R., et al. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.7.2403 · Cited by 116
Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E
Mensenkamp, A. R., Havekes, L. M., Romijn, J. A., & Kuipers, F. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00249-5 · Cited by 96
Hepatitis C Virus Nonstructural Proteins Inhibit Apolipoprotein B100 Secretion
Domitrovich, A. M., Felmlee, D. J., & Siddiqui, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510391200 · Cited by 70
Hepatitis C Virus Subgenomic Replicons in the Human Embryonic Kidney 293 Cell Line
Ali, S., Pellerin, C., Lamarre, D., & Kukolj, G. (2003) · Journal of Virology · doi:10.1128/jvi.78.1.491-501.2004 · Cited by 67
Higashi, Y., Itabe, H., Fukase, H., Mori, M., Fujimoto, Y., & Takano, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301376200 · Cited by 38
Hepatic Regulation of Apolipoprotein B
Avramoglu, R. K., & Adeli, K. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000045100.66675.92 · Cited by 37
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Replication of hepatitis C virus
Moradpour, D., Penin, F., & Rice, C. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1645 · Cited by 1,336
Dengue Virus-Induced Autophagy Regulates Lipid Metabolism
Heaton, N. S., & Randall, G. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.10.006 · Cited by 705
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
Scheel, T. K. H., & Rice, C. M. (2013) · Nature Medicine · doi:10.1038/nm.3248 · Cited by 554
Phospholipid Remodeling in Physiology and Disease
Wang, B., & Tontonoz, P. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114444 · Cited by 527
Metadata
- Authors
- Huang, H., Sun, F., Owen, D. M., Li, W., Chen, Y., Gale, M., & Ye, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-04-03
- Volume
- 104
- Issue
- 14
- Pages
- 5848-5853
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2094733152
- Cited by
- 533
- References
- 40
- FWCI
- 28.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.